Medical oncology coordinators online now

Immunotherapytrain your own immune system to find the cancer

Immunotherapy is a cancer treatment that removes the brakes tumours put on the immune system, letting a patient's own T-cells find and attack cancer cells. Different drug classes are matched to a tumour's biomarkers and used alongside or instead of chemotherapy, depending on the cancer type.

Trusted by 1000+ patients — guidance and updates in your own language

  • Reports reviewed free
  • Answer within 1 hour
  • No advance payment
4,000+
Cancer patients guided
40–70%
Cheaper than Western drug pricing
4 hrs
Senior oncologist opinion
1 hr
Cost estimate turnaround
Chat with an Immunotherapy Coordinator

What immunotherapy actually costs

Immunotherapy is priced per cycle, not per course — so the honest question is what one cycle costs and how many you need. Set your situation below. Your exact figure comes back within 1 hour of us seeing the reports.

Per-cycle and full-course planner

Lung (non-small cell)

The biggest immunotherapy success story. If PD-L1 is 50% or higher and there is no EGFR or ALK mutation, single-agent pembrolizumab alone can work for years. Below 50%, it is combined with chemotherapy. Driver mutations must be excluded first — targeted tablets beat immunotherapy in those patients.
68 kg

Several checkpoint inhibitors are dosed per kilogram, so weight moves the price directly. Flat-dose options exist and we quote both.

12
Indicative cost per cycle
$1,040 – $1,500
Full course of 12 cycles
$12,500 – $18,000
About $40,200 less than typical Western pricing
Get my exact written per-cycle estimate

Every cycle quote includes

  • The drug itself — brand or biosimilar named in writing
  • Day-care infusion suite, nursing and pre-medication
  • Oncologist consultation before each cycle
  • Pre-cycle blood counts, liver, kidney and thyroid panels
  • Immune side-effect monitoring and a 24/7 escalation number
  • Response scans at the agreed intervals, quoted separately and upfront

Lung (non-small cell)

Tests that decide
PD-L1 TPS · EGFR/ALK negative · TMB
Typical response
45–60% with chemo-immunotherapy
Where it fits
First line, and after chemoradiation in stage III

The biggest immunotherapy success story. If PD-L1 is 50% or higher and there is no EGFR or ALK mutation, single-agent pembrolizumab alone can work for years. Below 50%, it is combined with chemotherapy. Driver mutations must be excluded first — targeted tablets beat immunotherapy in those patients.

Indicative ranges only. The real driver is body weight for weight-based dosing, whether a flat-dose or biosimilar option exists, whether chemotherapy or a targeted tablet is combined with it, and how many cycles you actually need. We share a written per-cycle estimate and a full-course projection before you travel.

45-second eligibility check

Four questions. No sign-up, no phone number.

Has a biopsy confirmed the cancer type?
Has PD-L1, MSI/MMR or NGS testing been done on the tumour?
Are you able to look after yourself and stay out of bed most of the day?
Are you free of active autoimmune disease and high-dose steroids?

Next: see if your own biomarkers make you a strong candidate

Will immunotherapy work for you? Check your biomarkers.

Immunotherapy is the most biomarker-dependent treatment in oncology. Set what your reports say below — or leave "not tested" to see how much the gaps are costing you in certainty.

Educational estimate only. It is not a prescription, does not replace an oncologist, and cannot account for your cancer's stage, previous treatments or organ function.

52%
biomarker match
Likely candidate — combination regimen

Immunotherapy is very likely to be part of your plan, most often combined with chemotherapy for the first few cycles. The exact combination depends on the cancer type and what testing is still missing.

Ask an oncologist about this profile

Immunotherapy is not one drug — see the five families

Five ways to switch the immune system on

"Immunotherapy" is not one drug. Tap a class to see what it blocks, what it is called, and who it suits.

tap a class to reveal its mechanism

PD-1 inhibitors

Pembrolizumab, Nivolumab

The most widely used class and the backbone of most immunotherapy plans. Given as a 30-minute infusion every 2, 3 or 6 weeks, often alongside chemotherapy for the first few cycles. Works best when PD-L1 is expressed, MSI is high or the tumour mutation burden is high — but responses do happen outside those groups. Is this class right for me?

Drag through what actually happens, week by week

Immunotherapy works on a completely different clock to chemotherapy. Knowing the timeline stops good treatment being abandoned at the wrong moment.

Week 0Week 3–6Week 9–12Week 12Month 6Year 2
Week 0

First infusion

The drug does nothing to the tumour directly. It unmasks it — your T-cells now have to find it, multiply and get inside. Nothing on a scan yet.

30–60 min
Infusion time
2–6 weeks
Cycle interval
Week 9–12
First response scan

What side effects actually look like, organ by organ

Side effects: what to watch, and when to call

Immune side effects are not chemotherapy side effects. They can appear in any organ, weeks or even months after a dose — and almost all are manageable if reported early.

Skin

15–25%

Rash, itching, vitiligo patches

Antihistamines and steroid cream. Rarely stops treatment — and vitiligo often signals the drug is working.

Monitor

Thyroid

8–15%

Fatigue, weight change, feeling cold or hot

Thyroid blood tests before every cycle. Usually managed with a daily thyroxine tablet, treatment continues.

Monitor

Gut / colon

5–12%

Diarrhoea, cramping, blood or mucus in stool

Report the same day. Four or more extra stools a day means steroids now — untreated colitis is the classic emergency.

Call the same day

Liver

5–10%

Usually silent, found on blood tests

Liver panel before every cycle. Rising enzymes pause the drug and start steroids before you ever feel unwell.

Blood tests catch it

Lung

3–5%

New cough, breathlessness on stairs, chest tightness

Stop, CT chest and steroids the same day. Pneumonitis is the most dangerous side effect and the most treatable when caught early.

Call the same day

Endocrine (pituitary, adrenal)

1–4%

Severe fatigue, headache, dizziness, low blood pressure

Cortisol and pituitary hormones checked. Hormone replacement may be lifelong, but treatment can usually continue.

Blood tests catch it

Heart

<1%

Palpitations, chest pain, sudden breathlessness

Rare but serious. Immediate ECG, troponin and cardiology review. Baseline ECG is taken for exactly this reason.

Call the same day

Joints and muscles

5–10%

Stiff, aching joints or muscle weakness

Usually responds to short steroid courses and physiotherapy without stopping the drug.

Monitor

Call us the same day if any of these appear

Immune side effects are treatable when caught in days and dangerous when caught in weeks. These are the symptoms that should never wait for the next scheduled cycle.

  • Four or more extra loose stools a day, or blood in the stool
  • New cough or breathlessness climbing stairs you managed last week
  • Yellowing of the eyes or dark urine
  • Severe fatigue with dizziness or a persistent headache
  • Chest pain, palpitations or sudden ankle swelling
  • Rash covering large areas, blistering, or ulcers in the mouth
Report a symptom on WhatsApp

Immunotherapy or chemotherapy — the honest comparison

ImmunotherapyChemotherapy
How it worksRemoves the brakes on your own T-cellsKills any rapidly dividing cell
Who responds20–60%, depending on biomarker30–50% in most solid tumours
How long responses lastOften years; sometimes durable after stoppingUsually months; relapse is the norm
Hair lossNoCommon
Nausea and vomitingUncommonCommon, needs premedication
Blood countsLargely unaffectedDrops; infection risk between cycles
Main riskImmune attack on thyroid, gut, lung, liverInfection, neuropathy, marrow suppression
Infusion time30–60 minutes2–6 hours
Working through treatmentMost patients continue workingOften not for a week per cycle

They are not rivals. In lung, bladder, breast, gastric and head and neck cancer the two are given together, because chemotherapy releases tumour antigens that make immunotherapy work better.

Your immunotherapy journey, step by step

From the first WhatsApp message to cycles taken at home.

  1. 1

    Send the biopsy and scans on WhatsApp

    Day 0

    The histopathology report, any IHC or molecular report you already have (PD-L1, MSI, EGFR, ALK), the latest CT or PET-CT, and a list of treatments already given. Photos of paper reports are fine.

  2. 2

    Free senior medical oncologist opinion

    Within 4 hours

    A medical oncologist tells you honestly whether immunotherapy is likely to help, what still needs testing before starting, and whether chemotherapy, a targeted tablet or a trial would serve you better.

  3. 3

    Biomarker testing plan

    Day 1–3

    If PD-L1, MSI/MMR or NGS has not been done, we arrange it on your existing paraffin block — no repeat biopsy in most cases. Turnaround is 3–7 days and the block can be shipped ahead of you.

  4. 4

    Written per-cycle cost and visa letter

    Within 1 hour of reports

    An itemised per-cycle estimate with the drug brand named, biosimilar alternatives priced side by side, a full-course projection, and a hospital invitation letter issued in 2–4 hours for you and your attendant.

  5. 5

    Baseline safety work-up

    Day 1 after arrival

    Thyroid, cortisol, liver, kidney and glucose baselines, hepatitis and TB screening, and a review of any autoimmune history — the checks that make immune side effects catchable early instead of dangerous.

  6. 6

    First infusion

    30–60 minutes

    Given in a day-care chair through a vein or port. Most patients feel nothing during it, walk out the same afternoon, and can eat and travel normally the next day.

  7. 7

    Cycles and the first response scan

    Week 9–12

    Cycles every 2, 3 or 6 weeks. The first response assessment is deliberately delayed to 9–12 weeks because immunotherapy can make a tumour look bigger before it shrinks — pseudo-progression.

  8. 8

    Continue at home, reviewed on WhatsApp

    Month 3 onwards

    Many patients take later cycles in their own country while our oncologist reviews each scan and blood panel. Six-weekly flat dosing means as few as eight trips a year, and often none.

What immunotherapy can and cannot do

These are typical figures across the cancers we handle most. Immunotherapy is powerful in the right patient and useless in the wrong one — the honesty is the point, and it is why we test before we treat.

  • Roughly 20–60% of correctly selected patients respond, depending on cancer type and biomarker
  • Responses that do happen last far longer than chemotherapy responses — often years
  • About 10–20% of responders stay in remission after stopping the drug at two years
  • MSI-high and PD-L1-high tumours respond two to three times more often
  • Around 10–15% develop a serious immune side effect needing steroids
  • Roughly 5–8% show pseudo-progression — a scan that looks worse before it gets better

Living on immunotherapy — what nobody tells you

The card in your wallet

Any doctor treating you must know you are on a checkpoint inhibitor — diarrhoea or breathlessness is managed completely differently in you. We issue a card and a WhatsApp escalation line.

Steroids are not the enemy

Steroids treat immune side effects without abolishing the anti-cancer response in most cases. Delaying them out of fear is what turns a manageable colitis into a hospital admission.

Vaccines and infections

Inactivated vaccines including flu and COVID are fine and encouraged. Live vaccines are avoided. Tell us before any travel vaccination.

It can work after you stop

Immune memory persists. Patients stopped at two years are still followed with scans because relapse, when it happens, often responds to restarting the same drug.

Send the biopsy report. Get a real answer in 1 hour.

No forms, no payment, no obligation. A senior medical oncologist reads your reports and tells you honestly whether immunotherapy is likely to help you, what still needs testing, and what each cycle costs.

We reply on WhatsApp within 1 hour. Your reports are never shared with anyone else.

160 patients requested an immunotherapy estimate in the last 30 days

Visa, travel and treating cycles close to home

Immunotherapy is a long relationship, not a single trip. We build the plan around as few flights as possible — flat six-weekly dosing, cycles delivered in your own country between reviews, and paperwork that covers a whole course rather than one visit.

e-Medical Visa approved in 24–48 hours for all countries
Regular medical visa in 2–5 working days depending on country
Hospital invitation letter issued in 2–4 hours
Multi-entry medical visas for repeat cycles
Separate attendant visas for family members
Drug supply and prescription letters for cycles taken at home

Patients who have been through it

"PD-L1 came back at 80%. Pembrolizumab alone, no chemotherapy, no hair loss. Two years later the lung nodules are still gone and I never stopped working."

Grace O. · Lagos

"They found MSI-high on my old biopsy block that nobody had tested. That one test changed the whole treatment plan and the tumour has shrunk by more than half."

Bekzod R. · Tashkent

"Melanoma with liver spread. Combination immunotherapy, one thyroid problem managed with a tablet, and the scan at six months was clear. The price was a third of what we were quoted at home."

Amir H. · Dubai

What is immunotherapy?

Chemotherapy poisons dividing cells. Immunotherapy does something completely different — it removes the brakes that a tumour puts on your own immune system so your T-cells can recognise and kill the cancer themselves. Checkpoint inhibitors block the PD-1, PD-L1 or CTLA-4 switches that tumours use to hide; CAR-T therapy re-engineers your own T-cells in a lab and gives them back. It is not right for every cancer or every patient, which is exactly why biomarker testing comes before the first vial. When it works, responses can last years — sometimes long after the drug is stopped.

Cancers where immunotherapy is used

  • Non-small cell and small cell lung cancer
  • Melanoma and Merkel cell carcinoma
  • Kidney cancer (renal cell carcinoma)
  • Bladder and urothelial cancer
  • Head and neck squamous cell cancer
  • MSI-high / dMMR colorectal and endometrial cancer
  • Hodgkin lymphoma and relapsed B-cell lymphoma
  • Liver (HCC), oesophageal and gastric cancer
  • Triple-negative breast cancer (PD-L1 positive)
  • Cervical cancer and mesothelioma

Immunotherapy questions, answered straight

Send the biopsy report. Get a real answer in 1 hour.

No forms, no payment, no obligation. A senior medical oncologist reads your reports and tells you honestly whether immunotherapy is likely to help you, what still needs testing, and what each cycle costs.

6 patients are reading this page right now

WhatsAppChat Now